Present

IONIC SILVER
And its applications
Elaborated by :

Ionic Silver is nearly tasteless (slightly bitter), odourless and non-stinging to sensitive tissues. It may be taken orally, gargled, dropped into eyes or ears, poured on open wounds and burns, used vaginally, anally, atomized or inhaled into the nose or lungs.

Ionic silver features the following beneficial characteristics:

  • Being ionic it has a positive charge and thus is highly reactive, permitting it to strongly bind;
  • It is of such small size (10,000 times smaller then body cells) that it can easily pass thru cell membranes, where viruses reside.

    The silver ion has been proven to enhance the auto-immune system and thus helps to regenerate tissue and bone, eliminate oxidized cells and many other diseased or abnormal conditions.

    It is known to kill 650 different kinds of pathogens, including bacteria, fungus, viruses, germs, parasites such as Giardia by inhibiting the enzyme which allows their oxygen metabolism.

Environmental Protection Agency (EPA)
and the suggested daily intake:


The EPA reference dose (safe daily intake for life - 70 years 70 Kg person) of 5 PPM ionic silver is 14 teaspoons. This is based on the 90% elimination rate from a sensitive persons body in 24 hours.  The computed fatal dose is 500 gallons in one day.  Most references suggest 1 tablespoon per day as a supplement, much less then the EPA allowance.  Children under twelve would generally take one-half the adult dosage.  Many report excellent results with homeopathic doses of a few drops per day. The condition of your immune system and level of resident infections would of course determine required doses for good health.


Topical Uses  (Apply to a bandage or compress or directly on skin for):

Cuts
Scrapes
Open sores
Insect bites 
Warts
Eczema
Pink eye
Cold and Canker sores
Athletes foot
Acute cuticle infections
Eye and ear infections
Yeast infections
RingwormB
Burns
Flaky skin patches
Acne 
Sores
Pseudomonas
Psoriasis
Rashes
aeruginosa
Dandruff
Sun burns   

Oral Uses (For treatment of) :

Gum infections
General mouth infections
Epstein Barr Virus
Diverticulitus
Yeast infections
Gastritis
Malaria
Parasitic infections
Sinus infections
Bowel detoxification
Dysbiosis
Intestinal bacteria
Chronic Fatigue Syndrome
Candide Albicans
Cold and Flu

Has also been proven effective against other pathogens such as:

Allergies
Bladder infections
Inflammation
Blood-Poison
Boils
Candida Globata
Chilblains 
Cholera
Colitis
Cyst-isis
Dermatitis
Diphtheria
Diarrhea
Dysentery
Fibrosities
Fungal Infections
Gangrene
S.T.D.
Impetigo
Indigestion
Lymphangitis
Lyme Disease 
Malaria 
Meningitis
Multiple Sclerosis
Neurasthenia
Pneumonia
Pleurisy
Prostatitis
Rabbit Fever
Rheumatism
Rosacea 
Salmonella Typhi
Scarlet Fever
Shingles 
Staph Infections
Strep Infections
Stomach Ulcer 
Thyroid
Tonsillitis
Toxemia  
Trachoma
Trench-Foot
Tuberculosis

Before 1938,  many affectations and pathogens were successfully treated. However, the following is a documented list of silver-"resistant" bacteria (spelling as cited):

    1. Citrobacter Freundii  
    2. Enterobacter Cloacae
    3. Enterobacteriaceae (some strains)
    4. Klebsiella Pneumoniae  
    5. P. Stutzeri (some strains)
    6. Klebsiella Pneumoniae
    7. P. Stutzeri (some strains)
    8. Proteus Mirabilis
    9. Vegetative B. Cereus Spores

Bibliographic Footnotes:

1. Bechold, H. (1919). Colloids in biology and medicine, translated by J.G.M. Bullow. D. Van  Nostrand Co.: N-Yk, p. 367.
2. Ibid., p. 368.
3. Ibid., p. 376
4. Searle, A.B. (1919). The use of colloids in health and disease. (Quoting from the British  Medical Journal, May 12, 1917). 
    E.P. Dutton and ompany: New York, p.82.
5. Ibid., (Quoting from the British Medical Journal, Jan. 15, 1917), p.83.
6. Ibid., (Quoting from Sir James Cantlie in the British Medical Journal, Nov. 15, 1913), p. 83.
7. Ibid., (Quoting Henry Crookes), p.70.
8. Ibid., (Quoting J. Mark Hovell in the British Medical Journal, Dec. 15, 1917), p.86.
9. Ibid., (Quoting B. Seymour Jones), p. 86.
10. Ibid., (Quoting C.E.A. MacLeod in Lancet, Feb. 3, 1912), p.83
11. Ibid., (Quoting J. MacMunn in the British Medical Journal, 1917, I, 685), p.86.
12. Ibid., (Quoting Sir Malcom Morris in the British Medical Journal, May, 1917),  p.85.
13. Ibid., (Quoting A. Legge Roe in the British Medical Journal, Jan. 16, 1915), p. 83.
14. Ibid., (Quoting W.J. Simpson in Lancet, Dec. 12, 1914), pp. 71-72.
15. Ibid., (Quoting T.H. Anderson Wells in Lancet, Feb. 16, 1918), p. 85
16. (1931). Index-catalogue of the library of the surgeon generalÆs office united states army. United States Government Printing Office: Washington, v. IX, p. 628.
17. Moyasar, T.Y.: Landeen, L.K.; Messina, M.C.; Kutz, S.M.; Schulze, R.; and Gerba, C.P.  (1990). Disinfection of bacteria in water systems by using electrlytically generated copper:silver and reduced levels of free chlorine. Found in Canadian Journal of Microbiology. The National Research Council of Canada: Ottawa, Ont. Canada, pp. 109-116.   
18. Simonetti, N.; Simonetti, G; Bougnot, F.; and Scalzo, M. (1992) Electrochemical Ag+ for preservative use. Article found in Applied and Environmental Microbiology. American Society  for Microbiology: Washington, V. 58, 12, pp. 3834-3836.   
19. Slawson, R.M.; Van Dyke, M.I.; Lee, H.; and Trevors, J. T. (1992). Germanium and silver resistance, accumulations, and toxicity in microorganisms. Article found in Plasmid. Academic  Press, Inc.: San Diego, v. 27, 1, pp. 73-79.  
20. Thurman, R.B. and Gerba, C.P. (1989). The molecular mechanisms of copper and silver ion  disinfection of bacteria and viruses. A paper presented in the First International Conference  on Gold and Silver in Medicine. The Silver Institute: Washington, v. 18, 4, p. 295.  
21. Ibid., p. 299.
22. Ibid., p.300.
23. Ibid., p. 301
24. Ibid., p. 302.
25. Golden Health News, November 1995, Vol.2, No. 11.


Top of page
 
 

©Copyright MONNOL.COM - All right reserved